Literature DB >> 9703982

Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice.

Y Mitsumoto1, A Watanabe, A Mori, N Koga.   

Abstract

The spontaneous recovery of nigrostriatal dopaminergic neurons was quantitatively analyzed with tyrosine hydroxylase (TH)-immunocytochemistry in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated C57BL/6 young mice. A substantial reduction of striatal dopamine (DA) level was observed until 24 days following MPTP treatment. The TH-immunoreactive (IR) fibers and number of TH-positive cell bodies were also markedly reduced at 3 days after the toxin treatment. Thereafter, TH-IR fiber densities showed to progressively recover through the examining period. The number of TH-positive cell bodies in substantia nigra pars compacta were not changed during the recovery period. These results indicate that MPTP-treated mice have a potential for spontaneous regenerative sprouting in nigrostriatal dopaminergic system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9703982     DOI: 10.1006/bbrc.1998.8986

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson's disease.

Authors:  R Pattarini; R J Smeyne; J I Morgan
Journal:  Neuroscience       Date:  2007-01-29       Impact factor: 3.590

2.  Endotoxin induces a delayed loss of TH-IR neurons in substantia nigra and motor behavioral deficits.

Authors:  Yuxin Liu; Liya Qin; Belinda Wilson; Xuefei Wu; Li Qian; Ann-Charlotte Granholm; Fulton T Crews; Jau-Shyong Hong
Journal:  Neurotoxicology       Date:  2008-03-13       Impact factor: 4.294

3.  MPTP-induced executive dysfunction is associated with altered prefrontal serotonergic function.

Authors:  Panchanan Maiti; Laura C Gregg; Michael P McDonald
Journal:  Behav Brain Res       Date:  2015-09-21       Impact factor: 3.332

4.  The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron loss.

Authors:  Elizabeth M Kline; Laura M Butkovich; Joshua M Bradner; Jianjun Chang; Harris Gelbard; Val Goodfellow; W Michael Caudle; Malú G Tansey
Journal:  Exp Neurol       Date:  2019-05-08       Impact factor: 5.330

5.  Oral administration of coenzyme Q₁₀ reduces MPTP-induced loss of dopaminergic nerve terminals in the striatum in mice.

Authors:  Shota Kobayashi; Akiko Muroyama; Hiroaki Matsushima; Ikuo Yoshimura; Yasuhide Mitsumoto
Journal:  Neurol Sci       Date:  2011-05-20       Impact factor: 3.307

6.  Targeted deletion of GD3 synthase protects against MPTP-induced neurodegeneration.

Authors:  Y Akkhawattanangkul; P Maiti; Y Xue; D Aryal; W C Wetsel; D Hamilton; S C Fowler; M P McDonald
Journal:  Genes Brain Behav       Date:  2017-04-18       Impact factor: 3.449

7.  Estrogen attenuates glutamate-induced cell death by inhibiting Ca2+ influx through L-type voltage-gated Ca2+ channels.

Authors:  Eric A Sribnick; Angelo M Del Re; Swapan K Ray; John J Woodward; Naren L Banik
Journal:  Brain Res       Date:  2009-04-21       Impact factor: 3.252

8.  MPTP-treated mice: long-lasting loss of nigral TH-ir neurons but not paradoxical sleep alterations.

Authors:  Charlotte Laloux; Philippe Derambure; Alexandre Kreisler; Elise Houdayer; Servane Bruezière; Régis Bordet; Alain Destée; Christelle Monaca
Journal:  Exp Brain Res       Date:  2008-01-26       Impact factor: 1.972

Review 9.  Animal models of L-DOPA-induced dyskinesia: the 6-OHDA-lesioned rat and mouse.

Authors:  Elisabetta Tronci; Veronica Francardo
Journal:  J Neural Transm (Vienna)       Date:  2017-12-14       Impact factor: 3.575

10.  Hydrogen in drinking water reduces dopaminergic neuronal loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

Authors:  Kyota Fujita; Toshihiro Seike; Noriko Yutsudo; Mizuki Ohno; Hidetaka Yamada; Hiroo Yamaguchi; Kunihiko Sakumi; Yukiko Yamakawa; Mizuho A Kido; Atsushi Takaki; Toshihiko Katafuchi; Yoshinori Tanaka; Yusaku Nakabeppu; Mami Noda
Journal:  PLoS One       Date:  2009-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.